|
Market Closed -
Other stock markets
|
After market 04:30:10 am | |||
| 27.98 USD | +0.65% |
|
27.97 | -0.04% |
June 26 (Reuters) -
* US CDC ADVISERS RECOMMEND RSV VACCINE FOR ADULTS AGED 75 YEARS OF AGE AND ABOVE
* US CDC ADVISERS RECOMMEND RSV VACCINE FOR ADULTS 60–74 YEARS OF AGE WHO ARE AT INCREASED RISK OF SEVERE RSV DISEASE
* U.S. CDC ADVISERS DO NOT VOTE ON WHETHER TO RECOMMEND RSV VACCINE FOR ADULTS AGED 50 TO 59
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,530 GBX | +0.23% | -4.35% | 78.83B | ||
| 118.8 USD | -2.01% | -10.98% | 45.51B | ||
| 27.98 USD | +0.65% | +0.87% | 159B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -2.81% | 159B | |
| +55.32% | 815B | |
| +44.05% | 641B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +13.31% | 218B | |
| +8.48% | 168B | |
| +0.20% | 120B |
PFIZER, INC. 
